First Time Loading...
G

Gemini Therapeutics Inc
NASDAQ:GMTX

Watchlist Manager
Gemini Therapeutics Inc
NASDAQ:GMTX
Watchlist
Price: 19.89 USD 47.33% Market Closed
Updated: Jun 8, 2024

Gemini Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gemini Therapeutics Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
G
Gemini Therapeutics Inc
NASDAQ:GMTX
Total Equity
$176.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$8B
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
5%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$17.5B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$5B
CAGR 3-Years
-19%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$18.5B
CAGR 3-Years
27%
CAGR 5-Years
31%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$27B
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Gemini Therapeutics Inc's Total Equity?
Total Equity
176.6m USD

Based on the financial report for Dec 31, 2022, Gemini Therapeutics Inc's Total Equity amounts to 176.6m USD.

What is Gemini Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 1Y
41%

Over the last year, the Total Equity growth was 41%.